Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RNAZ

TransCode Therapeutics Inc

Apr 29 • 01:05PM ET

8.54

+0.09 1.07 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: MRNA AMGN GILD REGN VRTX ISRG ALNY INCY BIIB NBIX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-97.53	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-0.67%
Market Cap	7.83M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.83M	Perf Month	-0.47%
Enterprise Value	131.56M	PEG	-	EPS next Q	-	Inst Own	4.96%	Short Float	4.95%	Perf Quarter	-22.96%
Income	-36.27M	P/S	-	EPS this Y	-	Inst Trans	3.96%	Short Ratio	0.20	Perf Half Y	-35.01%
Sales	0.00M	P/B	0.76	EPS next Y	-	ROA	-40.85%	Short Interest	0.04M	Perf YTD	25.04%
Book/sh	11.27	P/C	0.44	EPS next 5Y	-	ROE	-46.26%	52W High	22.03 -61.23%	Perf Year	-29.40%
Cash/sh	19.42	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-23.88%	52W Low	6.08 40.39%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.78% 5.88%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	93.85%	Oper. Margin	-	ATR (14)	0.52	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.29	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.65	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.29	EPS Q/Q	89.80%	SMA20	-1.46%	Beta	1.46	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-6.50%	Rel Volume	0.01	Prev Close	8.45
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-14.02%	Avg Volume	207.81K	Price	8.54
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	1,473	Change	1.07%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)